{"id":8,"date":"2018-08-14T15:48:11","date_gmt":"2018-08-14T15:48:11","guid":{"rendered":"https:\/\/lab.research.sickkids.ca\/enrich\/?page_id=8"},"modified":"2026-02-06T20:16:12","modified_gmt":"2026-02-06T20:16:12","slug":"about-us","status":"publish","type":"page","link":"https:\/\/lab.research.sickkids.ca\/enrich\/about-us\/","title":{"rendered":"About Us"},"content":{"rendered":"

EnRICH Team: Enhancing Research Impact in Child Health<\/h1>\n<\/div>
\"EnRICH<\/span><\/div><\/div>

The EnRICH Lab in 2025, from left to right: Veronica Lai, Ami Baba, Martin Offringa, Atushi Patel, Andrea Chiaramida<\/span><\/p>\n<\/div>

<\/div><\/div><\/div>

SickKids\u2019 Principal Investigator Dr. Martin Offringa<\/strong><\/a>\u2019s<\/strong><\/span> program of research is captured under the Enhancing Research Impact in Child Health (EnRICH)<\/strong> program.<\/span><\/p>\n

In 2026, health research is questioned by the public. Does it really advance health and improve health outcomes? Are the efforts not wasted by design, conduct and reporting?<\/strong><\/a><\/span><\/p>\n

In response to these questions, new initiatives in partnership with patients, researchers, policymakers and other key stakeholders are underway. They all aim to strengthen the research enterprise and improve the quality and usefulness of scientific studies in biomedicine and beyond.<\/span><\/p>\n

Clinical research in children<\/strong> poses particular methodological, ethical and practical challenges. In the last 10 years, the paucity of safety and efficacy data informing the rational use of medicines has been recognized. New regulations have been implemented in the USA and in Europe which mandate proper clinical evaluations in children before any new drug can be labelled and licensed for adults.<\/span><\/p>\n

To inform decisions, whether at the bedside or policy level, researchers need to ensure their studies generate information that is reliable and relevant to decision makers.<\/strong> Current challenges include<\/span><\/p>\n